| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 18 | |
| #2 | WIPO (World Intellectual Property Organization) | 16 | |
| #3 | Australia | 9 | |
| #4 | China | 6 | |
| #5 | EPO (European Patent Office) | 6 | |
| #6 | Canada | 5 | |
| #7 | Mexico | 5 | |
| #8 | United States | 5 | |
| #9 | Republic of Korea | 4 | |
| #10 | Japan | 3 | |
| #11 | Brazil | 2 | |
| #12 | Argentina | 1 | |
| #13 | India | 1 | |
| #14 | Singapore | 1 | |
| #15 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Alterman Mathias | 38 |
| #2 | Hallberg Anders | 37 |
| #3 | Wu Xiongyu | 15 |
| #4 | Ljunggren Anders | 10 |
| #5 | Dahlöf Björn | 6 |
| #6 | Mathias Alterman | 6 |
| #7 | Subbaiah Murugaiah Andappan Mu | 5 |
| #8 | Malik Punam | 4 |
| #9 | Anders Hallberg | 4 |
| #10 | Wan Yiqian | 4 |
| Publication | Filing date | Title |
|---|---|---|
| GB202013721D0 | New compounds | |
| GB202012160D0 | New compositions | |
| GB202012152D0 | New compositions | |
| GB202009574D0 | New use | |
| GB202006074D0 | New composition | |
| GB202006081D0 | New composition | |
| GB202006079D0 | New composition | |
| GB202004209D0 | New use | |
| GB202004094D0 | New compounds and uses | |
| GB201917327D0 | New pharmaceutical use | |
| GB201916117D0 | New compositions | |
| GB201916130D0 | New compositions | |
| GB201916119D0 | New compositions | |
| GB201916121D0 | New compositions | |
| GB201913603D0 | New compounds | |
| GB201818164D0 | New composition | |
| GB201710906D0 | Compounds and methods for treating peripheral neuropathy | |
| WO2017221012A1 | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity | |
| GB201700238D0 | Prodrugs of an angiotensin receptor agonist | |
| CN107405406A | For treating the angiotensin-ii receptor activator of pulmonary fibrosis |